🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Surrozen, Inc.

Surrozen, Inc. logo
Market Cap: Lowest
Employees: Lowest

SZN-043, SZN-1326

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to modulate the Wnt pathway for tissue repair and regeneration. Its products focus on treating severe liver disease and modulating Wnt signaling in intestinal tissue.

Tags: Wnt pathway, antibodies, biotechnology, drug development, intestinal disease, liver disease, regeneration, tissue repair

Website

About | Contact | History | Leadership | Directors | About | Careers | About | About

Symbol: SRZN

Recent Price: $13.46

Industry: Biotechnology

CEO: Mr. Craig C. Parker M.B.A.

Sector: Healthcare

Employees: 42

Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 489 9000

Leadership

  • Craig Parker, MBA, Chief Executive Officer
  • Charles Williams, Chief Operating Officer and Chief Financial Officer
  • Yang Li, PhD, Executive Vice President, Research
  • David J. Woodhouse, PhD, Chairman, Surrozen / Chief Executive Officer, NGM Biopharmaceuticals
  • Anna Berkenblit, MD, MMS, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network
  • Chris Chai, Venture Partner, SR One
  • Mary Haak-Frendscho, Ph.D., President and Chief Executive Officer, Spotlight Therapeutics
  • Shao-Lee Lin, MD, PhD, Co-founder and Chief Executive Officer, ACELYRIN, INC.
  • Mace Rothenberg, M.D., Independent Board Member
  • Eric Bjerkholt, CFO of Chinook Therapeutics

Last updated: 2024-12-31